University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
NCT Number: NCT02596711
The goal of this research study is to learn how 3 different kinds of counseling treatments may help individuals to quit smoking.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 1 / Phase 2
Houston, Texas, 77030, United States
Baseline Visit:
If you agree to take part in this study, the following tests and procedures will be performed at the beginning of the study:
Study Groups:
You will be randomly assigned (as in the roll of dice) into 1 of 3 study groups. You will have an equal chance of being in each group. This is done because no one knows if one study group is better, the same, or worse than the other group.
Counseling Sessions:
The study group that you are in will determine the way that health information is presented to you in one-on-one counseling sessions.
All participants will attend 3 counseling sessions during the study. Each of these counseling sessions will be audio recorded. Your first counseling session will be at baseline. The other two counseling sessions will be at your Week 2 and Week 6 visits (described below).
All participants will be given a 12 week supply of nicotine patches and information about how to use the nicotine patch. At each study visit, you will be given the amount of patches that you need to last you to your next visit, plus a few extra in the event that a patch falls off or is damaged.
During your first counseling session, you will be asked to choose a quit date. This is simply a date that you would like to begin using the patch and make an attempt to not smoke.
Week 2 and Week 6 Study Visits:
At each of these study visits, all participants will have the following procedures:
Follow-Up Visits:
About 3 months and 6 months after baseline, you will have a follow-up visit. At each of these visits, the following tests and procedures will be performed:
Length of Study:
Your study participation will be over after you complete the 6-month follow-up visit.
This is an investigational study. Up to 36 people will be enrolled in this study. All will take part at MD Anderson.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants receive 4 weeks of 21 mg, 4 weeks of 14 mg, and 4 weeks of 7 mg patches.
Other names: NRT
Questionnaires regarding tobacco and alcohol use, culture, religion, and sense of control completed at baseline, at weeks 2 and 6, and at 3 and 6 months after baseline.
Other names: Surveys
Carbon monoxide (CO) test given at baseline, at weeks 2 and 6, and at 3 and 6 months after baseline.
Participants receive general health education and handouts.
Other names: Pamphlets
Participants given reading materials that highlight how aspects of their culture relate to health, smoking and quitting.
Other names: Pamphlets
Participants attend 3 counseling sessions during the study.
Time frame: Averaged across 3 study visits (Week 0 to Week 12)
The central aim of this pilot study was to evaluate the feasibility and acceptability of our treatment interventions. As such, we examined between-group differences on session satisfaction. After completing each session, participants anonymously rated their level of satisfaction with the counseling session. This investigator created scale (Session Satisfaction Scale) used a 5-point Likert scale (from 1 = "Extremely Unsatisfied" to 5 = "Extremely Satisfied"). Mean satisfaction scores were computed for each participant as the average of all session satisfaction scores. Higher scores indicating greater levels of satisfaction. Treatment group session satisfaction group means were tabulated by group (calculated as the average for all participants in each treatment group) and used as a proxy measure of overall intervention acceptability and feasibility.
Time frame: This outcome was collected at each study timepoint and measured the 12 weeks of NRT patch treatment.
Adherence to NRT patch (days of NRT patch use) collected with the Timeline followback interview procedure.
Time frame: Collected at the 3- and 6-month follow-up visits
Rates of biochemically verified 7-day point prevalence smoking abstinence. Collected with the Timeline Follow-back interview procedure and verified with a expired carbon monoxide testing with a Bedfont Smokelyzer monitor.
M.D. Anderson Cancer Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06629467
Behavior, Health Behavior
Oviedo, Principality of Asturias, Spain
View Trial DetailsNCT06458205
Behavior, Health Behavior
Zunyi, Guizhou, China
View Trial DetailsNCT05396911
Behavior, Electronic Cigarette Use
Charlottesville, Virginia, United States
View Trial DetailsNCT05952401
Behavior, Chemically-Induced Disorders
St Louis, Missouri, United States
View Trial Details